{"entity":{"id":"nct06858618","kind":"trial","name":"FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms","aka":[],"tldr":"A phase 2 trial of Azacitidine in advanced solid tumours, run by Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., active and no longer recruiting.","summary":"FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms is a phase 2 interventional study registered as NCT06858618 by Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., with 47 participants enrolled, started 2023-08-16 and due to reach its primary completion in 2026-12-01. Interventions recorded: FCN-338 + Azacitidine and FCN-338 + erythromycin+ Ara-C.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06858618","url":"https://clinicaltrials.gov/study/NCT06858618"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["azacitidine"],"companies":["shanghai-fosun-pharmaceutical-industrial-development"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06858618","phase":"2","setting":"A Phase II Clinical Study to Evaluate the Safety & Tolerability, Antitumor Activity, and Pharmacokinetics of FCN-338 in Combination With Azacitidine or Chemotherapy in Patients With Myeloid Neoplasms","sponsor":"Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.","enrolled":47,"outcomes":[]},"route":"/trials/nct06858618/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"azacitidine","kind":"drug","name":"Azacitidine","route":"/drugs/azacitidine/"}],"company":[{"id":"shanghai-fosun-pharmaceutical-industrial-development","kind":"company","name":"Shanghai Fosun Pharmaceutical Industrial Development","route":"/companies/shanghai-fosun-pharmaceutical-industrial-development/"}]}}